{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:48:53Z","timestamp":1791650933705,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shahid Sadoughi University of Medical Sceinces and Health Services","award":["3718"],"award-info":[{"award-number":["3718"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension, known as the silent killer, is a major risk factor for cardiovascular disease. Awareness and treatment of hypertension is not appropriate in the world, and this has led to an increase in mortality and morbidity caused by uncontrolled hypertension. This study aims to estimate awareness, treated, and controlled hypertensive and relevant predictors in an adult Iranian population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study was conducted on 10,000 adults aged 20\u201369\u2009years in Yazd, Iran. They were selected through multi-stage random cluster sampling in 2015\u20132016. Blood pressure was measured three-time with standard protocol by trained health workers. Those with a positive history of hypertension and using anti-hypertensive drugs, prescribed by a physician, were considered hypertensive. Hypertension was defined as systolic blood pressure\u2009\u2265\u2009140\u2009mmHg and\/or diastolic BP of \u226590\u2009mmHg. Uncontrolled hypertension was defined in accordance with recommended treatment targets by the Joint National Committee (JNC7). Logistic regression was used to assess the predictors of hypertension awareness, treatment and control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of hypertension was 37.3%, and the prevalence of pre-hypertension was 46.4%. 49.7% of People with hypertension were aware of their disease, and 71.5% of them were using antihypertensive drugs prescribed by physicians. Blood pressure was controlled in 38.9% of the treated patients. In the adjusted model, older age, female sex, and history of diabetes mellitus were positively associated with higher awareness. High physical activity, tobacco smoking, and diabetes are the only predictors of treated high blood pressure. Younger age, female sex, and higher education were determinants of controlled hypertension. Having health insurance was significantly correlated with awareness and control of hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hypertension is a public health problem in this population, which is not well controlled. Half of the patients were unaware. Intervention for increased screening coverage is needed. It should plan to raise public awareness about hypertension and improve hypertension control under the supervision of physicians. Implement a family physician program is recommended in the health system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-020-08831-1","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T04:04:22Z","timestamp":1589256262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Awareness, treatment, and control of hypertension and related factors in adult Iranian population"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-5023","authenticated-orcid":false,"given":"Mohsen","family":"Mirzaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6455-0747","authenticated-orcid":false,"given":"Masoud","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8482-0038","authenticated-orcid":false,"given":"Behnam","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-8035","authenticated-orcid":false,"given":"Ali","family":"Dehghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"key":"8831_CR1","doi-asserted-by":"publisher","unstructured":"Mouhtadi BB, Kanaan RMN, Iskandarani M, Rahal MK, Halat DH. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in Lebanese adults: a cross-sectional study. Glob Cardiol Sci Pract 2018;2018(1):6. http:\/\/doi.org\/https:\/\/doi.org\/10.21542\/gcsp.2018.6.","DOI":"10.21542\/gcsp.2018.6"},{"key":"8831_CR2","doi-asserted-by":"publisher","unstructured":"Forouzanfar MH, Afshin A, Alexander LT, Anderson HR, Bhutta ZA, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1659\u20131724. http:\/\/doi.org\/https:\/\/doi.org\/10.1016\/S0140-6736(16)31679-8.","DOI":"10.1016\/S0140-6736(16)31679-8"},{"key":"8831_CR3","doi-asserted-by":"publisher","unstructured":"Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1345\u20131422. http:\/\/doi.org\/https:\/\/doi.org\/10.1016\/S0140-6736(17)32366-8.","DOI":"10.1016\/S0140-6736(17)32366-8"},{"key":"8831_CR4","doi-asserted-by":"publisher","unstructured":"Salem H, Hasan DM, Eameash A, El-Mageed HA, Hasan S, Ali R. Worldwide prevalence of hypertension: A pooled meta-analysis of 1670 studies in 71 countries with 29.5 million participants. J Am Coll Cardiol. 2018;71. 11_Suppl: A1819. http:\/\/doi.org\/https:\/\/doi.org\/10.1016\/S0735-1097(18)32360-X.","DOI":"10.1016\/S0735-1097(18)32360-X"},{"key":"8831_CR5","doi-asserted-by":"publisher","unstructured":"Tailakh A, Evangelista LS, Mentes JC, Pike NA, Phillips LR, Morisky DE. Hypertension prevalence, awareness, and control in Arab countries: a systematic review. Nurs Health Sci 2014;16(1):126\u2013130. http:\/\/doi.org\/https:\/\/doi.org\/10.1111\/nhs.12060.","DOI":"10.1111\/nhs.12060"},{"issue":"4","key":"8831_CR6","first-page":"159","volume":"11","author":"M Mirzaei","year":"2016","unstructured":"Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980\u20132012: a systematic review. J Tehran Heart Cent. 2016;11(4):159\u201367.","journal-title":"J Tehran Heart Cent"},{"key":"8831_CR7","unstructured":"Institute for Health Metrics and Evaluation (IHME). Iran profile. Seattle: IHME, University of Washington. Available from http:\/\/www.healthdata.org\/iran. Accessed 22.11.2017."},{"key":"8831_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/ijpvm. IJPVM_103_16","volume":"8","author":"T Kazemi","year":"2017","unstructured":"Kazemi T, Hajihosseini M, Mashreghimoghadam H, Azdaki N, Ziaee M. Prevalence and determinants of hypertension among Iranian adults, Birjand. Iran Int J Prev Med. 2017;8:36. http:\/\/doi.org\/. https:\/\/doi.org\/10.4103\/ijpvm.IJPVM_103_16.","journal-title":"Iran Int J Prev Med"},{"key":"8831_CR9","doi-asserted-by":"publisher","unstructured":"Eghbali M, Khosravi A, Feizi A, Mansouri A, Mahaki B, Sarrafzadegan N. Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran. Epidemiol Health 2018;40:e2018020. https:\/\/doi.org\/https:\/\/doi.org\/10.4178\/epih.e2018020.","DOI":"10.4178\/epih.e2018020"},{"key":"8831_CR10","doi-asserted-by":"publisher","unstructured":"Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment, and control: data from the China health and retirement longitudinal study. Bull World Health Organ 2013;92:29\u201341. http:\/\/doi.org\/https:\/\/doi.org\/10.2471\/BLT.13.124495.","DOI":"10.2471\/BLT.13.124495"},{"key":"8831_CR11","doi-asserted-by":"publisher","unstructured":"Bloch MJ. The worldwide prevalence of hypertension exceeds 1.3 billion. J Am Soc Hypertens: JASH 2016;10(10):753\u2013754 http:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jash.2016.08.006.","DOI":"10.1016\/j.jash.2016.08.006"},{"key":"8831_CR12","doi-asserted-by":"publisher","unstructured":"Ghorbani Z, Shamshirgaran SM, Ghaffari S, Sarbakhsh P, Najafipour F, Aminisani N. Hypertension prevalence, awareness, treatment and its correlates among people 35 years and older: Result from the pilot phase of the Azar cohort study. J Educ Health Promot. 2018;7. 45. http:\/\/doi.org\/https:\/\/doi.org\/10.4103\/jehp.jehp_118_17.","DOI":"10.4103\/jehp.jehp_118_17"},{"issue":"7","key":"8831_CR13","first-page":"456","volume":"19","author":"A Esteghamati","year":"2016","unstructured":"Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Khajeh E, et al. Awareness, treatment and control of pre-hypertension and hypertension among adults in Iran. Arch Iran Med. 2016;19(7):456\u201364 http:\/\/doi.org\/0161907\/AIM.003.","journal-title":"Arch Iran Med."},{"issue":"6","key":"8831_CR14","first-page":"1455","volume":"15","author":"S Shirani","year":"2009","unstructured":"Shirani S, Kelishadi R, Sarrafzadegan N, Khosravi A, Sadri G, Amani A, et al. Awareness, treatment and control of hypertension, dyslipidemia and diabetes mellitus in an Iranian population: the IHHP study. East Mediterr Health J. 2009;15(6):1455\u201363.","journal-title":"East Mediterr Health J"},{"issue":"8","key":"8831_CR15","first-page":"335","volume":"21","author":"A Gandomkar","year":"2018","unstructured":"Gandomkar A, Poustchi H, Malekzadeh F, Malekzadeh MM, Moini M, Moghadami M, et al. Prevalence, awareness, treatment, control, and correlates of hypertension in the pars cohort study. Arch Iran Med. 2018;21(8):335\u201343.","journal-title":"Arch Iran Med"},{"issue":"1","key":"8831_CR16","first-page":"101","volume":"10","author":"Z Kalani","year":"2011","unstructured":"Kalani Z, Abdi H, Shahbazi L, Salimi T, Amini PM. Hypertension in the Yazd adult population. Payesh. 2011;10(1):101\u20137.","journal-title":"Payesh."},{"key":"8831_CR17","doi-asserted-by":"publisher","unstructured":"Mohamed SF MM, Wamai R, Wekesah F, Haregu T,Juma P, et al. Prevalence, awareness, treatment, and control of hypertension and their determinants: results from a national survey in Kenya. BMC Public Health. 2018;18 Suppl 3:1219. http:\/\/doi.org\/https:\/\/doi.org\/10.1186\/s12889-018-6052-y.","DOI":"10.1186\/s12889-018-6052-y"},{"key":"8831_CR18","doi-asserted-by":"publisher","unstructured":"Tesfaye B, Haile D, Lake B, Belachew T, Tesfaye T, Abera H. Uncontrolled hypertension and associated factors among adult hypertensive patients on follow-up at Jimma University teaching and specialized hospital: a cross-sectional study. Res Rep Clin Cardiol 2017;8:21\u201329. http:\/\/doi.org\/https:\/\/doi.org\/10.2147\/RRCC.S132126.","DOI":"10.2147\/RRCC.S132126"},{"key":"8831_CR19","doi-asserted-by":"publisher","unstructured":"Mirzaei M, Salehi-Abargouei A, Mirzaei M, Mohsenpour MA. Cohort Profile: The Yazd Health Study (YaHS): a population-based study of adults aged 20\u201370 years (study design and baseline population data). Int J Epidemiol. 2017;47(3):697-68h. http:\/\/doi.org\/https:\/\/doi.org\/10.1093\/ije\/dyx231.","DOI":"10.1093\/ije\/dyx231"},{"key":"8831_CR20","doi-asserted-by":"publisher","unstructured":"Ogedegbe G, Pickering T. Principles and techniques of blood pressure measurement. Cardio Clin 2010;28(4):571\u2013586. http:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.ccl.2010.07.006.","DOI":"10.1016\/j.ccl.2010.07.006"},{"key":"8831_CR21","doi-asserted-by":"publisher","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560\u20132571. http:\/\/doi.org\/https:\/\/doi.org\/10.1001\/jama.289.19.2560.","DOI":"10.1001\/jama.289.19.2560"},{"key":"8831_CR22","doi-asserted-by":"publisher","unstructured":"Tran TM, Giang NM. Changes in blood pressure classification, blood pressure goals, and pharmacological treatment of essential hypertension in medical guidelines from 2003 to 2013. IJC Metabolic & Endocrine 2014;2:1\u201310. http:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.ijcme.2014.01.001.","DOI":"10.1016\/j.ijcme.2014.01.001"},{"issue":"8","key":"8831_CR23","first-page":"1073","volume":"18","author":"MB Moghaddam","year":"2012","unstructured":"Moghaddam MB, Aghdam FB, Jafarabadi MA, Allahverdipour H, Nikookheslat SD, Safarpour S. The Iranian version of international physical activity questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World Appl Sci J. 2012;18(8):1073\u201380.","journal-title":"World Appl Sci J"},{"issue":"9403","key":"8831_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","author":"Expert Consultation WHO","year":"2004","unstructured":"Expert Consultation WHO. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157\u201363.","journal-title":"Lancet."},{"key":"8831_CR25","unstructured":"Statistical Centre of Iran. General Population and Housing Census (2016). Iran and Yazd profile. Available from: http:\/\/amarorgirAccessed 20 December 2016."},{"key":"8831_CR26","volume-title":"Age standardization of rates: a new WHO standard","author":"OB Ahmad","year":"2001","unstructured":"Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Geneva: World Health Organization 2001;9(10)."},{"key":"8831_CR27","doi-asserted-by":"publisher","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441\u2013450. http:\/\/doi.org\/https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018912.","DOI":"10.1161\/CIRCULATIONAHA.115.018912"},{"issue":"5","key":"8831_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/jhh.2012.33","volume":"27","author":"P Devi","year":"2013","unstructured":"Devi P, Rao M, Sigamani A, Faruqui A, Jose M, Gupta R, et al. Prevalence, risk factors and awareness of hypertension in India: a systematic review. J Hum Hypertens. 2013;27(5):281\u20137. http:\/\/doi.org\/. https:\/\/doi.org\/10.1038\/jhh.2012.33.","journal-title":"J Hum Hypertens"},{"key":"8831_CR29","doi-asserted-by":"publisher","unstructured":"Najafipour H, Nasri HR, Afshari M, Moazenzadeh M, Shokoohi M, Foroud A, et al. Hypertension: diagnosis, control status, and its predictors in general population aged between 15 and 75 years: a community-based study in southeastern Iran. Int J Public Health 2014;59(6):999\u20131009. http:\/\/doi.org\/https:\/\/doi.org\/10.1007\/s00038-014-0602-6.","DOI":"10.1007\/s00038-014-0602-6"},{"key":"8831_CR30","doi-asserted-by":"publisher","unstructured":"Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N, McAlister FA, Johansen H, Baclic O, Campbell N. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open 2013;3(8): e003423. http:\/\/doi.org\/https:\/\/doi.org\/10.1136\/bmjopen-2013-003423.","DOI":"10.1136\/bmjopen-2013-003423"},{"key":"8831_CR31","doi-asserted-by":"publisher","unstructured":"Babiker FA, Elkhalifa Lamia A, Moukhyer ME. Awareness of hypertension and factors associated with uncontrolled hypertension in Sudanese adults. Cardiovasc J Afr 2013;24(6):208\u2013212. http:\/\/doi.org\/https:\/\/doi.org\/10.5830\/CVJA-2013-035.","DOI":"10.5830\/CVJA-2013-035"},{"key":"8831_CR32","doi-asserted-by":"publisher","unstructured":"Katibeh M, Sanjari Moghaddam A, Yaseri M, Neupane D, Kallestrup P, Ahmadieh H. Hypertension and associated factors in the Islamic Republic of Iran: a population-based study. East Mediterr Health J 2020;26(3):301\u2013311. http:\/\/doi.org\/https:\/\/doi.org\/10.26719\/EMHJ.19.042.","DOI":"10.26719\/EMHJ.19.042"},{"key":"8831_CR33","doi-asserted-by":"publisher","unstructured":"Olives C, Myerson R, Mokdad AH, Murray CJ, Lim SS. Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001\u20132009. PLoS One 2013;8(4):e60308. http:\/\/doi.org\/https:\/\/doi.org\/10.1371\/journal.pone.0060308.","DOI":"10.1371\/journal.pone.0060308"},{"key":"8831_CR34","doi-asserted-by":"publisher","unstructured":"Malekzadeh MM, Etemadi A, Kamangar F, Khademi H, Golozar A, Islami F, et al. Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population. J Hypertens 2013;31(7):1364\u20131371. http:\/\/doi.org\/https:\/\/doi.org\/10.1097\/HJH.0b013e3283613053.","DOI":"10.1097\/HJH.0b013e3283613053"},{"key":"8831_CR35","doi-asserted-by":"publisher","unstructured":"Maimaris W, Paty J, Perel P, Legido-Quigley H, Balabanova D, Nieuwlaat R, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med 2013;10(7):e1001490. http:\/\/doi.org\/https:\/\/doi.org\/10.1371\/journal.pmed.1001490.","DOI":"10.1371\/journal.pmed.1001490"},{"key":"8831_CR36","doi-asserted-by":"publisher","unstructured":"Ware LJ, Chidumwa G, Charlton K, Schutte AE, Kowal P. Predictors of hypertension awareness, treatment, and control in South Africa: results from the WHO-SAGE population survey (wave 2). J Hum Hypertens 2019;33(2):157\u2013166. http:\/\/doi.org\/https:\/\/doi.org\/10.1038\/s41371-018-0125-3.","DOI":"10.1038\/s41371-018-0125-3"},{"key":"8831_CR37","doi-asserted-by":"publisher","unstructured":"Grossman A, Grossman E. Blood pressure control in type 2 diabetic patients. Cardiovasc Diabetol2017;16(1):3. http:\/\/doi.org\/https:\/\/doi.org\/10.1186\/s12933-016-0485-3.","DOI":"10.1186\/s12933-016-0485-3"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-08831-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-020-08831-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-08831-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T19:27:04Z","timestamp":1620761224000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-08831-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["8831"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-08831-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.22422\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22422\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22422\/v3","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study were approved by the ethics committee of Shahid Sadoughi University of Medical Science, Yazd, Iran (IR.SSU.MEDICINE.REC.1396.311). During the training of interviewers, principal investigator emphasis was placed on the importance of obtaining informed consent that informed that participants can choose not to answer any questions. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"667"}}